We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
6.4 quarters
Top 10 Avg Time Held
4.4 quarters
Top 20 Avg Time Held
3.3 quarters

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MIC icon
26
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$58.4M 1.17%
865,609
-228,759
-21% -$14.5M
2013 Q2
11 quarters
TYL icon
27
Tyler Technologies
TYL
$13.9B
$57.2M 1.15%
445,088
-139,271
-24% -$19.4M
2013 Q2
11 quarters
ELV icon
28
Elevance Health
ELV
$91.5B
$56.2M 1.13%
404,105
+99,284
+33% +$13.3M
2013 Q3
10 quarters
MKTX icon
29
MarketAxess Holdings
MKTX
$5.79B
$55.3M 1.11%
443,309
-12,133
-3% -$1.39M
2013 Q2
11 quarters
MCHP icon
30
Microchip Technology
MCHP
$40.1B
$53.5M 1.08%
2,218,818
-1,038,528
-32% -$23.1M
2013 Q2
11 quarters
MRK icon
31
Merck
MRK
$359B
$51.8M 1.04%
1,026,105
+504,476
+97% +$24.7M
2013 Q2
11 quarters
ALGN icon
32
Align Technology
ALGN
$9.98B
$51.8M 1.04%
712,194
+276,137
+63% +$18.1M
2013 Q2
11 quarters
NKE icon
33
Nike
NKE
$52.5B
$48.6M 0.98%
790,311
+272,316
+53% +$16.4M
2013 Q2
11 quarters
ECL icon
34
Ecolab
ECL
$79.7B
$48.6M 0.98%
435,541
+239,050
+122% +$25.4M
2013 Q2
11 quarters
CRM icon
35
Salesforce
CRM
$193B
$48M 0.97%
650,685
-172,403
-21% -$11.9M
2013 Q2
11 quarters
ULTA icon
36
Ulta Beauty
ULTA
$24.3B
$47.4M 0.95%
244,828
-87,954
-26% -$15.3M
2015 Q1
4 quarters
MHFI
37
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$47.4M 0.95%
479,078
+95,812
+25% +$8.59M
2013 Q4
9 quarters
BN icon
38
Brookfield
BN
$82.7B
$47M 0.95%
3,848,206
-52,333
-1% -$564K
2013 Q2
11 quarters
UNP icon
39
Union Pacific
UNP
$167B
$46.6M 0.94%
586,332
+12,369
+2% +$956K
2013 Q2
11 quarters
SHW icon
40
Sherwin-Williams
SHW
$77.7B
$46.2M 0.93%
486,849
+230,199
+90% +$20.1M
2014 Q4
5 quarters
CNC icon
41
Centene
CNC
$33.1B
$45.3M 0.91%
1,472,296
+563,904
+62% +$16.8M
2014 Q1
8 quarters
MIDD icon
42
Middleby
MIDD
$4.77B
$45.3M 0.91%
424,428
-43,790
-9% -$4.12M
2013 Q2
11 quarters
ACHC icon
43
Acadia Healthcare
ACHC
$2.8B
$43.9M 0.88%
796,498
-31,204
-4% -$1.78M
2013 Q2
11 quarters
CPAY icon
44
Corpay
CPAY
$26.1B
$43.2M 0.87%
290,554
+53,912
+23% +$7M
2013 Q2
11 quarters
SBAC icon
45
SBA Communications
SBAC
$19.5B
$43.1M 0.87%
429,992
-453,122
-51% -$43.3M
2013 Q2
11 quarters
ICLR icon
46
Icon
ICLR
$12.7B
$41.5M 0.83%
552,742
-36,005
-6% -$2.52M
2013 Q2
11 quarters
ADBE icon
47
Adobe
ADBE
$92.7B
$39.8M 0.8%
424,665
+156,510
+58% +$13.6M
2015 Q4
1 quarter
IDXX icon
48
Idexx Laboratories
IDXX
$41.3B
$39.3M 0.79%
502,225
+4,951
+1% +$357K
2014 Q4
5 quarters
TWX
49
DELISTED
Time Warner Inc
TWX
$39.2M 0.79%
540,069
-91,899
-15% -$6.33M
2013 Q2
11 quarters
CVS icon
50
CVS Health
CVS
$112B
$39M 0.78%
375,697
+68,968
+22% +$6.71M
2013 Q2
11 quarters

Similar funds

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.